Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices--influence of agitation rate and dissolution medium composition

International Journal of Pharmaceutics
Nicole Kavanagh, Owen I Corrigan

Abstract

The effect of dissolution medium variables, such as medium composition, ionic strength and agitation rate, on the swelling and erosion of Hypromellose (hydroxypropylmethylcellulose, HPMC) matrices of different molecular weights was examined. Swelling and erosion of HPMC polymers was determined by measuring the wet and subsequent dry weights of matrices. It was possible to describe the rate of dissolution medium uptake in terms of a square root relationship and the erosion of the polymer in terms of the cube root law. The extent of swelling increased with increasing molecular weight, and decreased with increasing agitation rate. The erosion rate was seen to increase with decrease in polymer molecular weight, with a decrease in ionic strength and with increasing agitation rate. The sensitivity of polymer erosion to the degree of agitation may influence the ability of these polymers to give reproducible, agitation-independent release, compared to more rigid non-eroding matrix materials, in the complex hydrodynamic environment of the gastrointestinal tract.

References

Jan 1, 1997·Journal of Microencapsulation·B A Heelan, O I Corrigan
Jan 1, 1997·Journal of Pharmaceutical Sciences·I KatzhendlerM Friedman
Mar 1, 1997·Journal of Pharmaceutical Sciences·B Narasimhan, N A Peppas
Sep 2, 1998·Journal of Pharmaceutical Sciences·T D ReynoldsL S Shenouda
Jun 1, 1999·Drug Development and Industrial Pharmacy·B AbrahamssonJ Sjögren
May 23, 2001·Advanced Drug Delivery Reviews·J Siepmann, N A Peppas
Jun 24, 2003·International Journal of Pharmaceutics·Rachel H GubbinsOwen I Corrigan

❮ Previous
Next ❯

Citations

Sep 9, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Inderbir SinghVikas Rana
Sep 7, 2006·Drug Development and Industrial Pharmacy·E Cedillo-RamírezA Hernández-León
Dec 29, 2006·Drug Development and Industrial Pharmacy·Yasser El-MalahCarey B Bottom
Oct 27, 2007·Drug Development and Industrial Pharmacy·Marina LevinaAli R Rajabi-Siahboomi
Feb 28, 2008·Drug Development and Industrial Pharmacy·Pablo Emilio Gutiérrez-SánchezLeopoldo Villafuerte-Robles
Mar 5, 2009·Drug Development and Industrial Pharmacy·M JugS Bengez
Oct 28, 2010·Expert Opinion on Drug Delivery·Grzegorz GarbaczWerner Weitschies
Jun 28, 2014·Expert Opinion on Drug Delivery·Ali Nokhodchi, Kofi Asare-Addo
Jul 7, 2007·Drug Development and Industrial Pharmacy·Lai Wah ChanPaul Wan Sia Heng
Apr 19, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cristina MaderueloJosé M Lanao
Feb 15, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Anna ViridénAnette Larsson
Nov 18, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Anna ViridénAnette Larsson
Sep 23, 2010·International Journal of Pharmaceutics·Hywel D WilliamsColin D Melia
Oct 5, 2010·International Journal of Pharmaceutics·Anna ViridénBengt Wittgren
Oct 12, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Panagiotis BarmpalexisEmanouil Georgarakis
Oct 13, 2010·International Journal of Pharmaceutics·Friederike EisenächerKarsten Mäder
Jul 14, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Grzegorz GarbaczWerner Weitschies
Nov 5, 2015·International Journal of Pharmaceutics·E I NepA M Smith
May 2, 2009·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Marta Gómez-BurgazSantiago Torrado
Dec 4, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Anna ViridénAnette Larsson
May 16, 2008·International Journal of Pharmaceutics·M Gómez-BurgazS Torrado-Santiago
Mar 11, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ai Ling ChingPaul Wan Sia Heng
Mar 3, 2007·The Journal of Pharmacy and Pharmacology·V R SinhaJ R Bhinge
Jul 20, 2007·The Journal of Pharmacy and Pharmacology·Shahla Jamzad, Reza Fassihi
Jun 30, 2006·International Journal of Pharmaceutics·María V Ramírez RigoRuben H Manzo
Feb 17, 2006·International Journal of Pharmaceutics·Shahla Jamzad, Reza Fassihi
Aug 28, 2014·Pharmaceutical Development and Technology·Wiwat PichayakornGarnpimol C Ritthidej
Jul 11, 2012·Pharmaceutical Development and Technology·Safwan Abdel RahimNizar Al-Zoubi
Nov 29, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Anna ViridénAnette Larsson
Oct 11, 2014·The Journal of Pharmacy and Pharmacology·Guanyu ChenJingyuan Wen
Nov 24, 2016·Pharmaceutical Development and Technology·Darjan KoširFranc Vrečer
Oct 1, 2016·AAPS PharmSciTech·Pompilia Ispas-SzaboMircea Alexandru Mateescu
Oct 24, 2017·Drug Development and Industrial Pharmacy·E I NepK Asare-Addo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.